Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics
Go back to Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics| (NASDAQ: OLK) | Delayed: 26.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.08 | 52 Week High | $ | |||
| Open | $26.08 | 52 Week Low | $ | |||
| Day High | $26.08 | P/E | N/A | |||
| Day Low | $26.08 | EPS | $ | |||
| Volume | 106,900 | |||||
| Thermo Fisher Scientific (NYSE: TMO) | Delayed: 482.03 +8.08 (1.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $473.95 | 52 Week High | $160.68 | |||
| Open | $482.13 | 52 Week Low | $119.75 | |||
| Day High | $488.65 | P/E | 137.72 | |||
| Day Low | $476.08 | EPS | $3.50 | |||
| Volume | 2,256,739 | |||||
